Upstream Bioprocessing Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global upstream bioprocessing market looks promising with opportunities in biopharmaceutical manufacturing companies and research organizations. The global upstream bioprocessing market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases, rising research activities for development of biosimilars/biomolecules, small therapeutic peptide and monoclonal antibodies, and growing demand for process optimization and contamination free, safe and efficient production of biomolecules.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global upstream bioprocessing market report, please download the report brochure.
In this market, bioreactors is the largest product type of upstream bioprocessing, whereas multi-use is the largest use type. Growth in various segments of the upstream bioprocessing market are given below:
The study includes trends and forecast for the global upstream bioprocessing market by product, workflow, use type, mode, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell Culture ProductsBioreactors/FermentersFilters, Bags & ContainersBioreactor Accessories and Others
By Workflow [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell CultureMedia PreparationCell Separation
By Use Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Single-UseMulti-Use
By Mode [Value ($ Million) shipment analysis for 2014 – 2025]:
OutsourcedIn-House
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the upstream bioprocessing companies profiled in this report include Thermo Fisher Scientific, GE Healthcare, Merck, Corning, Sartorius, Eppendorf, Applikon Biotechnology, Lonza, PBS Biotech, and CellGenix.
Lucintel forecasts that the bioreactors/fermenters will remain the largest segment over the forecast period due to its increasing demand in large as well small-scale bioproduction and development of automated bioreactors for safe, cost-effective, and regulatory-compliant manufacturing of cell-based products for clinical applications.
Within this market, multi-use will remain the largest segment by use type over the forecast period, as it is environment friendly and imposes lower environmental impact as compared to single-use.
North America will remain the largest region over the forecast period due to rising investment related to research and development of new biomolecules & mAbs, increasing prevalence of chronic diseases, and availability of developed healthcare infrastructure in the region.
Features of the Global Upstream Bioprocessing Market
Market Size Estimates: Global upstream bioprocessing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global upstream bioprocessing market size by various segments, such as product, workflow, use type, and mode in terms of value.Regional Analysis: Global upstream bioprocessing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, workflow, use type, mode, and region for the global upstream bioprocessing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global upstream bioprocessing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global upstream bioprocessing market by product (cell culture products, bioreactors/fermenters, filters, bags & containers, bioreactor accessories and others), workflow (cell culture, media preparation, and cell separation), use type (single-use and multi-use), mode (outsourced and in-house), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global upstream bioprocessing market?
Q.5 What are the business risks and threats to the global upstream bioprocessing market?
Q.6 What are the emerging trends in this upstream bioprocessing market and the reasons behind them?
Q.7 What are some changing demands of customers in this upstream bioprocessing market?
Q.8 What are the new developments in this upstream bioprocessing market? Which companies are leading these developments?
Q.9 Who are the major players in this upstream bioprocessing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this upstream bioprocessing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global upstream bioprocessing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others), Workflow (Cell Culture, Media Preparation, and Cell Separation), Use Type (Single-Use and Multi-Use), and Mode (Outsourced and In-House)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global upstream bioprocessing market looks promising with opportunities in biopharmaceutical manufacturing companies and research organizations. The global upstream bioprocessing market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases, rising research activities for development of biosimilars/biomolecules, small therapeutic peptide and monoclonal antibodies, and growing demand for process optimization and contamination free, safe and efficient production of biomolecules.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global upstream bioprocessing market report, please download the report brochure.
In this market, bioreactors is the largest product type of upstream bioprocessing, whereas multi-use is the largest use type. Growth in various segments of the upstream bioprocessing market are given below:
The study includes trends and forecast for the global upstream bioprocessing market by product, workflow, use type, mode, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell Culture ProductsBioreactors/FermentersFilters, Bags & ContainersBioreactor Accessories and Others
By Workflow [Value ($ Million) shipment analysis for 2014 – 2025]:
Cell CultureMedia PreparationCell Separation
By Use Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Single-UseMulti-Use
By Mode [Value ($ Million) shipment analysis for 2014 – 2025]:
OutsourcedIn-House
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the upstream bioprocessing companies profiled in this report include Thermo Fisher Scientific, GE Healthcare, Merck, Corning, Sartorius, Eppendorf, Applikon Biotechnology, Lonza, PBS Biotech, and CellGenix.
Lucintel forecasts that the bioreactors/fermenters will remain the largest segment over the forecast period due to its increasing demand in large as well small-scale bioproduction and development of automated bioreactors for safe, cost-effective, and regulatory-compliant manufacturing of cell-based products for clinical applications.
Within this market, multi-use will remain the largest segment by use type over the forecast period, as it is environment friendly and imposes lower environmental impact as compared to single-use.
North America will remain the largest region over the forecast period due to rising investment related to research and development of new biomolecules & mAbs, increasing prevalence of chronic diseases, and availability of developed healthcare infrastructure in the region.
Features of the Global Upstream Bioprocessing Market
Market Size Estimates: Global upstream bioprocessing market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global upstream bioprocessing market size by various segments, such as product, workflow, use type, and mode in terms of value.Regional Analysis: Global upstream bioprocessing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product, workflow, use type, mode, and region for the global upstream bioprocessing market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global upstream bioprocessing market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global upstream bioprocessing market by product (cell culture products, bioreactors/fermenters, filters, bags & containers, bioreactor accessories and others), workflow (cell culture, media preparation, and cell separation), use type (single-use and multi-use), mode (outsourced and in-house), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global upstream bioprocessing market?
Q.5 What are the business risks and threats to the global upstream bioprocessing market?
Q.6 What are the emerging trends in this upstream bioprocessing market and the reasons behind them?
Q.7 What are some changing demands of customers in this upstream bioprocessing market?
Q.8 What are the new developments in this upstream bioprocessing market? Which companies are leading these developments?
Q.9 Who are the major players in this upstream bioprocessing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this upstream bioprocessing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global upstream bioprocessing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others), Workflow (Cell Culture, Media Preparation, and Cell Separation), Use Type (Single-Use and Multi-Use), and Mode (Outsourced and In-House)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Upstream Bioprocessing Market Trends and Forecast
3.3: Global Upstream Bioprocessing Market by Product
3.3.1: Cell Culture Products
3.3.2: Bioreactors/Fermenters
3.3.3: Filters
3.3.4: Bags & Containers
3.3.5: Bioreactor Accessories and Others
3.4: Global Upstream Bioprocessing Market by Workflow
3.4.1: Cell Culture
3.4.2: Media Preparation
3.4.3: Cell Separation
3.5: Global Upstream Bioprocessing Market by Use Type
3.5.1: Single-Use
3.5.2: Multi-Use
3.6: Global Upstream Bioprocessing Market by Mode
3.6.1: Outsourced
3.6.2: In-House
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Upstream Bioprocessing Market by Region
4.2: North American Upstream Bioprocessing Market
4.2.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.2.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.2.3: Market by Use Type: Single-Use and Multi-Use
4.2.4: Market by Mode: Outsourced and In-House
4.2.5: The United States Upstream Bioprocessing Market
4.2.6: The Canadian Upstream Bioprocessing Market
4.2.7: The Mexican Upstream Bioprocessing Market
4.3: European Upstream Bioprocessing Market
4.3.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.3.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.3.3: Market by Use Type: Single-Use and Multi-Use
4.3.4: Market by Mode: Outsourced and In-House
4.3.5: The Upstream Bioprocessing Market of United Kingdom
4.3.6: The German Upstream Bioprocessing Market
4.3.7: The French Upstream Bioprocessing Market
4.4: APAC Upstream Bioprocessing Market
4.4.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.4.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.4.3: Market by Use Type: Single-Use and Multi-Use
4.4.4: Market by Mode: Outsourced and In-House
4.4.5: The Chinese Upstream Bioprocessing Market
4.4.6: The Indian Upstream Bioprocessing Market
4.4.7: The Japanese Upstream Bioprocessing Market
4.5: ROW Upstream Bioprocessing Market
4.5.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.5.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.5.3: Market by Use Type: Single-Use and Multi-Use
4.5.4: Market by Mode: Outsourced and In-House
4.5.5: Brazilian Upstream Bioprocessing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Upstream Bioprocessing Market by Product
7.1.2: Growth Opportunities for the Global Upstream Bioprocessing Market by Workflow
7.1.3: Growth Opportunities for the Global Upstream Bioprocessing Market by Use Type
7.1.4: Growth Opportunities for the Global Upstream Bioprocessing Market by Mode
7.1.5: Growth Opportunities for the Global Upstream Bioprocessing Market by Region
7.2: Emerging Trends in the Global Upstream Bioprocessing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Upstream Bioprocessing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Upstream Bioprocessing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific, Inc
8.2: GE Healthcare
8.3: Merck KGaA
8.4: Corning, Inc.
8.5: Sartorius AG
8.6: Eppendorf AG
8.7: Applikon Biotechnology
8.8: Lonza Group Ltd.
8.9: PBS Biotech, Inc.
8.10: CellGenix GmbH
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Upstream Bioprocessing Market Trends and Forecast
3.3: Global Upstream Bioprocessing Market by Product
3.3.1: Cell Culture Products
3.3.2: Bioreactors/Fermenters
3.3.3: Filters
3.3.4: Bags & Containers
3.3.5: Bioreactor Accessories and Others
3.4: Global Upstream Bioprocessing Market by Workflow
3.4.1: Cell Culture
3.4.2: Media Preparation
3.4.3: Cell Separation
3.5: Global Upstream Bioprocessing Market by Use Type
3.5.1: Single-Use
3.5.2: Multi-Use
3.6: Global Upstream Bioprocessing Market by Mode
3.6.1: Outsourced
3.6.2: In-House
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Upstream Bioprocessing Market by Region
4.2: North American Upstream Bioprocessing Market
4.2.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.2.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.2.3: Market by Use Type: Single-Use and Multi-Use
4.2.4: Market by Mode: Outsourced and In-House
4.2.5: The United States Upstream Bioprocessing Market
4.2.6: The Canadian Upstream Bioprocessing Market
4.2.7: The Mexican Upstream Bioprocessing Market
4.3: European Upstream Bioprocessing Market
4.3.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.3.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.3.3: Market by Use Type: Single-Use and Multi-Use
4.3.4: Market by Mode: Outsourced and In-House
4.3.5: The Upstream Bioprocessing Market of United Kingdom
4.3.6: The German Upstream Bioprocessing Market
4.3.7: The French Upstream Bioprocessing Market
4.4: APAC Upstream Bioprocessing Market
4.4.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.4.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.4.3: Market by Use Type: Single-Use and Multi-Use
4.4.4: Market by Mode: Outsourced and In-House
4.4.5: The Chinese Upstream Bioprocessing Market
4.4.6: The Indian Upstream Bioprocessing Market
4.4.7: The Japanese Upstream Bioprocessing Market
4.5: ROW Upstream Bioprocessing Market
4.5.1: Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.5.2: Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.5.3: Market by Use Type: Single-Use and Multi-Use
4.5.4: Market by Mode: Outsourced and In-House
4.5.5: Brazilian Upstream Bioprocessing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Upstream Bioprocessing Market by Product
7.1.2: Growth Opportunities for the Global Upstream Bioprocessing Market by Workflow
7.1.3: Growth Opportunities for the Global Upstream Bioprocessing Market by Use Type
7.1.4: Growth Opportunities for the Global Upstream Bioprocessing Market by Mode
7.1.5: Growth Opportunities for the Global Upstream Bioprocessing Market by Region
7.2: Emerging Trends in the Global Upstream Bioprocessing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Upstream Bioprocessing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Upstream Bioprocessing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Therm Fisher Scientific, Inc
8.2: GE Healthcare
8.3: Merck KGaA
8.4: Corning, Inc.
8.5: Sartorius AG
8.6: Eppendorf AG
8.7: Applikon Biotechnology
8.8: Lonza Group Ltd.
8.9: PBS Biotech, Inc.
8.10: CellGenix GmbH
